دورية أكاديمية

Combination ATR and PARP Inhibitor (CAPRI): A phase 2 study of ceralasertib plus olaparib in patients with recurrent, platinum-resistant epithelial ovarian cancer

التفاصيل البيبلوغرافية
العنوان: Combination ATR and PARP Inhibitor (CAPRI): A phase 2 study of ceralasertib plus olaparib in patients with recurrent, platinum-resistant epithelial ovarian cancer
المؤلفون: Shah, Payal D., Wethington, Stephanie L., Pagan, Cheyenne, Latif, Nawar, Tanyi, Janos, Martin, Lainie P., Morgan, Mark, Burger, Robert A., Haggerty, Ashley, Zarrin, Haley, Rodriguez, Diego, Domchek, Susan, Drapkin, Ronny, Shih, Ie-Ming, Smith, Simon A., Dean, Emma, Gaillard, Stéphanie, Armstrong, Deborah, Torigian, Drew A., Hwang, Wei-Ting, Giuntoli, Robert, Simpkins, Fiona
المصدر: Gynecologic Oncology ; volume 163, issue 2, page 246-253 ; ISSN 0090-8258
بيانات النشر: Elsevier BV
سنة النشر: 2021
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
مصطلحات موضوعية: Obstetrics and Gynecology, Oncology
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/j.ygyno.2021.08.024
الإتاحة: https://doi.org/10.1016/j.ygyno.2021.08.024Test
https://api.elsevier.com/content/article/PII:S0090825821013226?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0090825821013226?httpAccept=text/plainTest
حقوق: https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://creativecommons.org/licenses/by-nc-nd/4.0Test/
رقم الانضمام: edsbas.B1F937C3
قاعدة البيانات: BASE